The cellular mechanisms mediating nitric oxide (NO) modulation of the inhibitory transmission in the nucleus tractus solitarii (NTS) remain unclear, even though this could be extremely important for various physiological and pathological processes. Specifically, in the NTS NO-evoked glutamate and ␥-aminobutyric acid (GABA) release might contribute to pathological hypertension. In cultured rat brainstem slices, NTS GABAergic neurons were targeted using an adenoviral vector to express enhanced green fluorescent protein and studied with a combination of patch clamp and confocal microscopy. Low nanomolar concentrations of NO increased intracellular Ca 
] i ⅐ patch clamp
Nitric oxide (NO), a fascinating gaseous signaling molecule, has attracted the attention of numerous neuroscientists and has been implicated in a wide variety of brain functions, such as learning and memory, central autonomic control, neurodegeneration, and hormonal secretion, to name but a few. This laboratory has been focused for several years on the role of NO in central control of autonomic homeostasis with emphasis on the nucleus tractus solitarii (NTS). Indeed, the functional significance of NO signaling within the NTS has been well documented and particular attention has been paid to NO modulation of the baroreceptor reflex pathway, an action implicated in hypertension (for reviews see refs. 1, 2). However, attempts to clarify the actual role that NO plays in the NTS produced discordant results with some suggesting potentiation of the baroreflex (3) (4) (5) , whereas others demonstrated either NO-mediated inhibitory actions (6 -8) or no effect (9, 10) . These differences might be attributable to a multiplicity of NO actions, including its ability to evoke both glutamate and ␥-aminobutyric acid (GABA) release. Although the effects of NO on glutamatergic synapses have been studied extensively (11, 12 ; for reviews see refs. 13, 14) , very little is known about its effects on inhibitory GABAergic transmission, although this could be at least as important for various physiological and pathological processes. Indeed GABAergic inhibition is fundamental for brain function and gets involved in all aspects of its activity. Overexpression of endothelial NO synthase (eNOS) in the rostral ventrolateral medulla led to elevation of extracellular concentrations of glutamate and GABA (15) . Similarly, in striatum NO donors increased the release of both GABA and glutamate (16) . However, the mechanism of these effects remains unknown and it is unclear whether NO-induced release of GABA results from a direct action on GABAergic neurons or an indirect effect via an increase in network activity driven by release of glutamate. To our knowledge, the most convincing evidence of a direct effect of NO on GABAergic neurons comes from the study by Li et al. (17) , which demonstrated an increase in spontaneous GABAergic postsynaptic currents after application of an NO donor in the paraventricular nucleus of the hypothalamus (see also ref. 18) .
NO could modulate GABAergic transmission by altering excitability of the GABAergic neurons (e.g., by depolarizing the membrane potential) or by a direct modulation of the transmitter release machinery. At presynaptic terminals, transmitter release is frequently regulated via changes in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) either by modulation of external Ca influx or release from intracellular stores (10) . Concerning the latter, the NO-cGMP pathway has been demonstrated to activate Ca 2ϩ release from ryanodinesensitive stores in sea urchin eggs (19) and glia (20) . The NO-cGMP-Ca 2ϩ pathway has also been implicated in the mechanisms of excitatory synaptic plasticity in the hippocampus (21, 22) and cerebellum (23) . Whether these findings also apply to GABAergic transmission and to other areas of the brain is unknown. Therefore, we studied NO actions specifically on GABAergic inhibitory interneurons in the NTS. Specifically, we tested a hypothesis that NO has a direct effect on these neurons via an evolutionary conserved cGMPcyclic adenosine diphosphate ribose (cADPR)-Ca 2ϩ pathway, initially described in sea urchin eggs (19, 24, for review see ref. 25) .
MATERIALS AND METHODS

Preparation of organotypic brainstem slice cultures
Slice cultures were prepared as described previously (26) . Briefly, a Wistar rat pup (P8 -10) was terminally anesthetized by halothane; the brainstem was dissected out and bathed in ice-cold dissection medium. Two-hundred and fifty micrometer thick slices containing the NTS were cut in cold (4°C) sterile dissection solution and then kept in dissection saline on ice for 1 h. Millicell-CM organotypic culture inserts (Millipore) were placed in sixwell culturing plates and moistened by addition of 1.0 ml OPTI-MEM based plating medium containing 30 l adenoviral vector suspension to the side of each well. Two or three slices were deposited on each insert and the excessive medium was aspirated from the membrane surface. Slices were incubated at 37°C in a 5% CO 2 atmosphere. After 3 days, the plating medium was exchanged for Neurobasal-based culturing medium, which was subsequently exchanged twice a week. Slice cultures were allowed to settle for at least 7 days before being used for experimentation. For more details, including the composition of the media, see Teschemacher et al. (26) .
The adenoviral vector used to visualize GABAergic neurons contains 3.7 Kb of GAD67 (glutamic acid decarboxylase) promoter sequence plus the first exon-intron sequence that drives expression of enhanced green fluorescent protein [enhanced GFP (EGFP); see also refs 26,27] . GAD67 is the key enzyme in the synthesis of GABA, and a shorter version of this sequence was used previously to target GABAergic neurons in a transgenic mouse (28) . Thus, this vector induces expression of EGFP specifically in GABAergic neurons, which can be identified subsequently by fluorescence microscopy. This vector has different degrees of specificity in different areas of the brain, but in the NTS the absolute majority of EGFP-expressing neurons is immunopositve for GABA (26, 27) , see also Supplementary Figs. 1 and 2.
Confocal imaging and electrophysiological recordings
All the imaging experiments were performed using a laserscanning confocal microscope (SP-1 Leica) built on a fixed stage. A cultured slice was transferred to a glass bottomed chamber. The slice was superfused continuously with artificial cerebrospinal fluid (ACSF, see ref. 29 and in the experiments in acute slices described below) at 31 Ϯ 1°C. For whole-cell patch clamp recordings, EGFP-expressing GABAergic interneurons were first identified in the NTS using conventional epifluorescence. The final stages of approaching the target neuron with a patch pipette (3-5 M⍀) and the formation of a seal were performed using the confocal scanner. The 488 nm wavelength line of the argon laser was used to excite EGFP, whereas the 633 nm Helium-Neon laser line was applied to obtain a differential interference contrast (DIC) image via a light detector located beneath the recording chamber. DIC optics greatly facilitated visualization of the slice surface and the pipette tip. Once the whole cell configuration was established, the identity of the patched neuron could be confirmed by the appearance of EGFP in the mouth of the patch pipette. Electrophysiological recordings were performed using the whole-cell mode. For Ca 2ϩ imaging, cells were loaded with the Ca 2ϩ indicator Rhod-2. The intracellular solution used in these experiments contained the following (in mM): 130 potassium gluconate, 10 HEPES, 5.5 EGTA, 4 NaCl, 2 MgCl 2 , 1 CaCl 2 , 2 ATP, 0.5 GTP, 5 glucose, and 0.5 of Rhod-2. Changes in [Ca 2ϩ ] i were assessed by relative fluorescence intensity (F/F 0 , where F indicates peak fluorescence intensity and F 0 denotes resting fluorescence intensity). The Rhod-2 was excited using a green Helium-Neon laser line (543 nm), typically at levels of Ͻ0.5 mW, and Rhod-2-emitted light was sampled within the 560 -640 nm band, as defined by the spectral scan head. In most cases, there was a big difference in fluorescence intensity between the soma, dendrite, and axon in the same image, and we therefore used two channels to sample Rhod-2 fluorescence (a low sensitivity channel for cell soma and a high sensitivity channel for neuronal dendrites and axons). This allowed us to obtain noiseless and unsaturated individual images of each cellular compartment.
No signs of any detrimental action of adenoviral vectors on neurons could be detected. Indeed, the EGFP-expressing neurons survived in vitro for weeks, essentially for as long as the slice culture remained viable. The morphology of the transduced cells is perfectly preserved; they demonstrate no swelling or segmentation of the soma or EGFP leakage. Electrophysiologically (resting membrane potential, spike amplitude, and membrane resistance) these neurons were similar to an "average" NTS neuron, as recorded in our previous studies using blind whole cell patch in acute NTS slices.
Electrophysiological recording in acute slices
Experiments were performed using brainstem slices of young rats (Wistar; postnatal days 12-15) prepared as described previously (29) . Slices were placed into a conventional superfusion chamber, and neuronal recordings from the caudal NTS were made using the whole cell patch clamp configuration. Patch pipettes were filled with the same intracellular solution as described above but without Rhod-2 and containing 11 mM EGTA. The slices were superfused continuously with ACSF at a flow rate of 2 ml/min at 31 Ϯ 5°C. Signals were amplified using a SEC-05LX amplifier (NPI), and the data were acquired and analyzed using Spike2 software (Cambridge Electronic Design).
Synaptic potentials were evoked by electrical stimulation via a concentric bipolar stimulating electrode (0.2 ms pulsewidth, 0.5-5 V, 0.3 Hz). When there was stimulation within the ipsilateral solitary tract, monosynaptic connections were apparent in Ͻ10% of neurons recorded, consistent with previously published observations (29 -31) . Therefore, to record monosynaptic inhibitory postsynaptic potentials (IPSPs), we applied 20 M 6-cyano-7-nitroxaline-2,3-dione (CNQX, a blocker of non-NMDA receptor-mediated fast glutamatergic transmission), stimulated electrically within the central part of the NTS, and randomly searched for neurons with CNQX-resistant IPSPs (typically 1 of 5-6 recorded cells, Supplementary Fig. 3 ). The evoked monosynaptic IPSPs had invariable latency Յ2 ms. IPSPs were recorded at holding potentials of Ϫ58 to Ϫ45 mV (those were kept unchanged for each individual cell for the duration of the recording) so that GABAergic events appeared hyperpolarizing. Because the EPSPs recorded in the medial NTS were mediated predominantly by non-NMDA receptors (30, 31) , only CNQX was used in this study to block polysynaptic connections. Indeed, 20 M CNQX in our experiments completely blocked EPSPs in all cells where they were tested (data not shown). The recordings of evoked IPSPs commenced at least 10 min after whole-cell configuration was established. The amplitude of IPSPs at their peaks was measured from an average value for at least 10 consecutive IPSPs. According to previous data from our laboratory, IPSPs recorded in the NTS were in almost all cases sensitive to the GABA A receptor blocker bicuculline (32) ; therefore, in this study we assumed that they were mediated by GABA A receptors.
Drugs and their application
Diethylamine NONOate (DEA/NO) was dissolved in alkaline solution (10 mM NaOH) as concentrated stock solution and stored at Ϫ80°C. Thawing was allowed only before use when it was diluted into ACSF and used immediately. The half-life of DEA/NO at 37°C is 2 min and 16 min at 22-25°C To estimate the actual effective concentration of NO at the recording site, we measured the real concentration of NO released by DEA/NO within the recording chamber using an electrochemical NO sensor (Amino-700, Innovative Instruments, see Supplementary Materials for more detail).
Statistical analysis
All values in this text are mean Ϯ se. Differences were examined using Student's paired t test, unpaired t test with Welch's correction, and one-way ANOVA with Post hoc Tukey's test, as appropriate and indicated in the text. P Ͻ 0.05 was considered significant. Statistical evaluation was carried out using Microsoft Excel and GraphPad Prism 4.
RESULTS
Initially we confirmed that both DEA/NO (see below) and aqueous solutions of NO ( Supplementary Fig. 4 ) potentiate monosynaptic IPSPs in acute NTS slices. We therefore proceeded to investigate the possible mechanisms of NO effect on GABAergic neurons in organotypic slice cultures.
Effects of DEA/NO on NTS GABAergic interneurons in organotypic brainstem slice cultures
NTS GABAergic neurons transfected with adenoviral vector to express EGFP displayed a resting membrane potential of Ϫ58 Ϯ 1 mV, input resistance of 195 Ϯ 7 M⍀, and action potential amplitude of 85 Ϯ 2 mV (nϭ57). Not only neuronal somata, but also dendrites and, in some cases, initial segments of axons could be visualized in Rhod-2-loaded cells (Fig. 1) . The putative axons usually were Ͻ1 M in cross-section and stemmed from a pyramid-like protrusions on the cell body ( Fig. 1) .
Effect of DEA/NO on [Ca 2ϩ ] i in GABAergic neurons
According to the measurements performed using the electrochemical NO sensor placed into the recording chamber of the confocal microscope, 1 and 10 M DEA/NO generated 17 Ϯ 7 and 121 Ϯ 9 nM of NO (nϭ3 in both cases) in ACSF saturated with carbogen, (see Supplementary Materials). Application of 1 and 10 M DEA/NO increased [Ca 2ϩ ] i in somata of GABAergic neurons in a concentration-dependent manner ( Fig. 2A) Ten micromoles of DEA/NO also caused a moderate and reversible ODQ-sensitive depolarization in 66% (6 of 9) of the neurons (ϩ3.4Ϯ1 mV, Fig. 3A) . However, depolarization occurred much later than the rises in [Ca 2ϩ ] i at a latency of 73 Ϯ 9 s (Fig. 3A-C) .
DEA/NO effect on [Ca 2ϩ ] i in GABAergic neurons is independent of synaptic transmission
To investigate whether the DEA/NO effect on GABAergic neurons is direct, a glutamate receptor inhibitor CNQX (20 M) was used. In slice cultures pretreated with CNQX for 10 min, the evoked rises in [Ca 2ϩ ] i (Fig.  4A and B) and depolarization in five of six cells (P Ͻ 0.05, Fig. 3B ) were unaffected after application of DEA/NO (10 M). Thus, DEA/NO action is unlikely to result from glutamate release through polysynaptic connections. Moreover, bath application of 1 M TTX also failed to prevent DEA/NO-induced increases in [Ca 2ϩ ] i (nϭ5, data not shown) and depolarizations (nϭ6, Fig. 3C Fig. 6A ).
Blockade of ryanodine-sensitive stores by 8-Br-cADPR abolishes effects of DEA/NO cADPR is thought to be an endogenous activator of ryanodine-sensitive Ca 2ϩ stores (36 -38) . To test for the involvement of the cADPR/ryanodine-sensitive store, 8-Br-cADPR, a selective antagonist of cADPR, which has been reported to block cADPR-induced calcium release (39 -41) but fails to block IP 3 -sensitive stores (35) , was introduced from the patch pipette (100 M in the patch pipette solution). In the presence of 8-Br-cADPR, DEA/NO failed to evoke [Ca 2ϩ ] i elevations in seven of eight neurons. In addition, membrane depolarization was essentially abolished (ϩ1Ϯ0.4 mV; nϭ8). Therefore, cADPR-sensitive Ca 2ϩ stores are most likely to be the key link in the mechanism of NO action of GABAergic neurons (Fig. 6A and B) .
NO-mediated potentiation of monosynaptic IPSP is mediated by cADPR
Having found that DEA/NO effects on [Ca 2ϩ ] i in GABAergic neurons are mediated by cADPR, experiments were performed in acute brainstem slices to test whether cADPR also mediates potentiation of monosynaptic GABAergic IPSPs. The NTS neurons recorded in these experiments had characteristics essentially identical to those found in our previous studies (29) , e.g., mean resting membrane potential of Ϫ61 Ϯ 2 mV, mean input resistance of 363 Ϯ 64 M⍀, and mean action potential amplitude of 85 Ϯ 2 mV. The experiments were performed in the presence of CNQX to cancel potential effects related to NO acting via glutamatergic mechanisms. Monosynaptic IPSP evoked from the medial portions of NTS in the presence of CNQX had invariable latency Յ2 ms. As shown in Fig. 7 , 1 M DEA/NO (which, according to the electrochemical NO sensor, released Ϸ55 nM of NO, see Supplementary Materials) potentiated IPSPs by Ϸ32%. This effect was reversible (Fig. 7) and could be repeated after 10 to 15 min of wash (not shown). DEA/NO-induced IPSP potentiation was essentially abolished by pretreatment with 30 M 8-Br-cADPR (Fig 7A and B; PϽ0.01 as compared with DEA/NO only group and not significantly different from control, PϾ0.05). Thus, NO potentiates monosynaptic GABAergic IPSPS via a cADPRdependent mechanism. 
DISCUSSION
Our results lend support to the hypothesis of a direct stimulation of GABA exocytosis by NO and suggest that potentiation of Ca 2ϩ release from cADPR/ryanodinesensitive stores is the principal mechanism of NOinduced effect on the inhibitory transmission, at least in the NTS. In brain tissue under normal conditions, NO originates predominantly from two sources: neuronal NOS and eNOS. In the intact brain, the enzymatic activity of NOS subtypes, their expression levels in different cellular compartments, sensitivity of glutamatergic and GABAergic neurons to NO, and the spatial relationships between the sources of NO and its targets would together determine the functional impact of NO-mediated signaling. Overall, the effective NO concentrations reported in our study are consistent with the EC 50 values for activation of sGC by NO, which in different studies range from 20 to 45 nM (42) down to 2 nM (43) in intact brain cells.
NTS microinjections of the NO precursor l-arginine can induce baroreceptor reflex-like responses (i.e., falls in both arterial pressure and heart rate; refs 44, 45), whereas microdialysis of NO increased the extracellular concentration of glutamate consistent with facilitation of glutamatergic transmission (46, 47) ; this could account for the depressor/bradycardia noted above. On the other hand, chronic blockade of eNOS in the NTS increased baroreflex sensitivity (7), whereas both the NO donor and l-arginine depressed the baroreflex through an ODQ-sensitive mechanism in the working heart-brainstem preparation (6) . The latter action strongly suggests that NO recruits an inhibitory mechanism in the NTS. Certainly, the GABAergic neurons are the obvious candidates for such a mechanism.
GABAergic inhibition is a fundamental feature of essentially any brain circuit, and therefore modulation of GABA release by NO must have far-reaching functional implications. Although the effects of NO on glutamatergic transmission have been studied extensively, there is no information about the mechanisms through which NO could modulate GABAergic transmission. Our study provides novel information to fill in this gap.
Ca
2؉ release from cADPR-ryanodine sensitive stores is a key element in NO action on GABAergic neurons
We have investigated the mechanisms of NO actions in organotypic slice cultured using an adenoviral vector to fluorescently label GABAergic neurons (26, 27) . Neurotransmitter release depends on action potentialevoked influx of Ca 2ϩ through voltage-operated channels, an effect amplified by Ca 2ϩ -induced Ca 2ϩ release from Ca 2ϩ -dependent ryanodine-sensitive store. The latter can be modulated by cADPR, which makes it a good candidate for modulation by NO. In addition, even in the absence of Ca 2ϩ influx, exocytosis can be stimulated by Ca 2ϩ release from stores (48) . NO has been reported to increase [Ca 2ϩ ] i in sea urchin eggs (19) and rat parotid acinar cells (49) . In cultured glial cells, micromolar concentrations of NO evoked Ca 2ϩ release from ryanodine-sensitive stores (20) . Consistent with these observations, nanomolar concentrations of NO increased [Ca 2ϩ ] i in GABAergic neurons in the present study (Fig. 2) This effect of NO was most dramatic in putative axons (Fig. 2B and D) , suggesting that axonal release sites may be strongly modulated by NO. The factors responsible for the differential sensitivity of individual compartments may involve different concentrations of sGC, the potency of endogenous Ca 2ϩ buffers, and spatial distribution of intracellular stores (reviewed in ref. 50) . Our results could explain the recently reported NO donor-induced cGMP-mediated increase in the frequency of miniature GABAergic inhibitory postsynaptic currents in neurons of paraventricular nucleus (17) . NO also potentiated [ 3 H]GABA release from primary neurons of mouse cerebral cortex through several mechanisms, including influx of external Ca 2ϩ -and Na ϩ -dependent reversed GABA transporter (51, 52) . However, these effects were to a large degree mediated by peroxynitrite, rather than cGMP. In contrast, all effects on GABAergic neurons in this study are cGMP-mediated, as ODQ completely eliminated both NO-induced [Ca 2ϩ ] elevations and depolarization. Consistent with this notion, NO-induced cGMP accumulation in GABAergic fibers has been documented in the magnocellular nucleus of the hypothalamus (53) . It must be acknowledged that although NO has been reported to trigger Ca 2ϩ release from mitochondria in striatal neurons via a non-cGMPdependent mechanism (54), the concentrations of NO used in that study were very high (4 -10 M), which is much higher than those used in our study.
cADPR is generated from NAD by ADP-ribosyl cyclase. cADPR binds to the same sites as ryanodine (discussed in refs. 50, 55) triggering Ca 2ϩ release (56) . In sea urchin eggs, cGMP mobilizes intracellular Ca 2ϩ via stimulation of cADPR synthesis (24) . The effects of NO on [Ca 2ϩ ] i in the present study were also cGMPmediated and therefore could lead to activation of ADP-ribosyl cyclase, which is consistent with observations made in neurosecretory PC12 cells (57) . Importantly, cADPR/ryanodine-sensitive stores are also responsible for the Ca Whether the NO-cGMP-cADPR-Ca 2ϩ pathway is sufficiently powerful to lead to action potential-independent GABA release is at present unclear, although some data suggest that this might be the case, at least in the hypothalamus (17) . Our results provide a mechanistic explanation for the increase in the frequency of miniature GABAergic inhibitory postsynaptic currents in neurons of paraventricular nucleus reported in that study.
Here we directly demonstrate that potentiation of monosynaptic GABAergic IPSPs in the NTS depends on cADPR-mediated signaling, as its antagonist, 8-BrcADPR, eliminates the effects of NO (Fig. 7) . In these experiments, glutamatergic receptors were blocked with CNQX and therefore the effect of 8-Br-cADPR was mediated by its direct action on GABAergic neurons. It remains to be established whether activation of cADPR/ryanodine-sensitive stores also underlies the NO effects on glutamatergic transmission.
ADP-ribosyl cyclase also catalyzes conversion of NAD phosphate into NAADP. NAADP has been suggested to operate a separate Ca 2ϩ channel in some cellular systems (61, 62). Thus, NO/cGMP/PKG/ADP-ribosyl cyclase cascade might be expected to have a NAADPdependent component. In terms of our results, DEA/ NO-induced [Ca 2ϩ ] i increases were to some extent inhibited by high concentrations of nifedipine (Fig.  6A) , consistent with partial involvement of NAADPsensitive store. However, more selective blockers are 8-Br-cADPR for 15 min, followed by addition of 1 M DEA/NO. 8-Br-cADPR had no effect on IPSPs alone but abolished DEA/NO action (no significant difference compared with control in DEA/NOϩ8-Br-cADPR group). In preliminary experiments, we confirmed that the effect of DEA/NO is reproducible in the same cell after 10 -15 min of wash (not shown). B) Pooled data illustrate that pretreatment with 8-Br-cADPR blocked the DEA/NO-induced potentiation of monosynaptic IPSPs in 5/5 cells. **P Ͻ 0.01, compared with control (paired t test).
## P Ͻ 0.01, compared with group treated with DEA/NO and CNQX only, unpaired t test.
needed to convincingly prove such a mechanism. Finally, we found no evidence for the involvement of IP 3 -sensitive stores in the action of NO on GABAergic neurons (Fig. 6A and Supplementary Fig. 5 ) consistent with the mechanism originally described in sea urchin eggs (19) .
It may be asked whether the depolarization triggered by DEA/NO in many GABAergic neurons could lead to Ca 2ϩ entry through voltage-operated membrane channels, which could be registered as an increase in [Ca 2ϩ ] i . We believe that this pathway has only a minor role, if any. First, NO-stimulated [Ca 2ϩ ] i rises were observed in some neurons without depolarization. Second, preventing depolarization by negative current injection in a small subset of neurons did not prevent [Ca 2ϩ ] i increases. Third, the latency-to-onset of elevations of [Ca 2ϩ ] i (Ϸ20 s) was much shorter than that of membrane depolarization (Ͼ1 min), indicating that Ca 2ϩ is released before depolarization. Finally, although depolarization by current injection to the same concentration as that evoked by DEA/NO also increased [Ca 2ϩ ] i in the soma and dendrites, this increase was much smaller than the changes observed after DEA/NO administration (Fig. 5) .
The effect on GABAergic neurons is direct, this conclusion being based on the experiments with CNQX to block AMPA receptors and TTX, which blocks action potentials and therefore the action potential-induced transmitter release (see "DEA/NO effect on [Ca 2ϩ ] i in GABAergic neurons is independent of synaptic transmission"). Indeed, TTX strongly inhibits release of neurotransmitters and must have suppressed or abolished any effects related to release of glutamate, including some potential unforeseen actions via metabotropic receptors. However, neither CNQX nor TTX had any clear effect on DEA/NOinduced Ca 2ϩ elevations, which makes glutamate involvement highly unlikely.
Effects of NO on resting membrane potential
In our experiments, NO depolarized many GABAergic neurons in organotypic slice cultures and also unidentified NTS neurons in acute slices (data not shown). Depolarization of the GABAergic neurons could be abolished by a sGC inhibitor but not by a Na ϩ channel blocker TTX or CNQX (Fig. 3) , indicating that NO action is direct and not mediated by excitatory network interactions. NO-induced depolarization of GABAergic neurons and sensitization of Ca 2ϩ stores in these cells may act synergistically to potentiate inhibitory transmission. Similar effects have been previously reported in several studies. In thalamic neurons, NO-induced depolarization resulted from a shift in activation of hyperpolarization-activated inward cationic conductance (63) . Comparable effects were observed in paraventricular nucleus of hypothalamus (64) , trigeminal motoneurons (65) , and Aplysia central neurons (66) . The mechanism underlying this depolarization is still unknown, but it has been proposed that cGMP modulates channel proteins via phosphorylation and/or dephosphorylation.
In conclusion, low nanomolar concentrations of NO may directly engage GABAergic inhibition via cGMPmediated release of Ca 2ϩ from axonal stores through an evolutionary conserved NO/cGMP/ADP-ribosyl cyclase/Ca 2ϩ pathway. This effect may be assisted by membrane depolarization of some NTS GABAergic neurons and lead to the inhibitory NO actions seen at the systems level.
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injections by Ϸ5 mV (more than that induced by 10 M DEA/NO). Within 3 min, F/F 0 in soma increased by 10 Ϯ 2% and in dendrites by 14 Ϯ 4%, which was significantly less than that after DEA/NO administration. ] i increases (Fig. 1). 
A possible role for nicotinic acid adenine dinucleotide phosphate-sensitive store?
Nicotinic acid adenine dinucleotide phosphate (NAADP) might operate an independent Ca 2ϩ release mechanism, and this pathway can be blocked by high concentrations (100 M) of an L-type Ca 2ϩ channel blocker nifedipine. Pretreatment with 100 M nifedipine did not completely block DEA/NO action but reduced DEA/NO-induced [Ca 2ϩ ] i rises from 20 Ϯ 4 to 12 Ϯ 4% (nϭ4/5; PϽ0.05; Fig. 1 ).
8-Bromo-cADPR (8-Br-cADPR) is a key link between NO and elevations in [Ca 2ϩ ] i
cADPR is thought to be an endogenous activator of ryanodine-sensitive Ca 2ϩ stores. To test for the involvement of these stores 8-bromo-cADPR (8-Br-cADPR; 100 M), a highly selective antagonist of cADPR that does not block IP 3 -sensitive stores, was introduced from the patch pipette directly into the GABAergic neurons. In the presence of 8-Br-cADPR, DEA/NO failed to evoke [Ca 2ϩ ] i elevations (Fig. 1) . Membrane depolarization was also almost abolished. Therefore, NO acts via cADPR-sensitive Ca 2ϩ stores to elevate [Ca 2ϩ ] i in GABAergic neurons.
cADPR mediates NO-induced potentiation of GABAergic inhibitory postsynaptic potentials
Having found that DEA/NO effects on [Ca 2ϩ ] i in GABAergic neurons are mediated by cADPR, we tested in acute brainstem slices whether cADPR also mediates the NO-induced potentiation of monosynaptic GABAergic inhibitory postsynaptic potentials (IPSPs). Experiments were performed in the presence of CNQX to cancel potential indirect effects related to release of glutamate. 1 M DEA/NO (which released Ϸ55 nM of NO) potentiated IPSP by Ϸ32%. DEA/NO-induced IPSP potentiation was essentially abolished by pretreatment with 30 M 8-Br-cADPR. Thus, NO potentiates monosynaptic GABAergic IPSP via a cADPR-dependent mechanism.
CONCLUSIONS AND SIGNIFICANCE
GABAergic inhibition is fundamental for brain function and is involved in all aspects of its activity. Our results lend support to the hypothesis of direct stimulation of GABA exocytosis by NO. We have found that potentiation of Ca 2ϩ release from cADPR/ryanodinesensitive stores is the principle mechanism by which NO enhances inhibitory transmission, at least in the NTS. This means that at least in some parts of the central nervous system NO may modulate not only excitatory but also inhibitory connections. We propose that the functional destiny of NO release may depend on both the threshold concentrations of NO required for affecting glutamatergic and GABAergic neurons and the spatial relationship between the sources of NO (i.e., the NO synthases) and its targets. Importantly, all effects reported in this study are mediated by sGC and therefore not related to other mechanisms characteristic of high NO concentrations, such as effects on ## P Ͻ 0.01, compared with group treated with DEA/NO alone, unpaired t test. cellular respiration, direct modification of proteins, or formation of the products of NO oxidation.
NO has a direct effect on GABAergic neurons
Several studies indicate that NO can elevate extracellular concentrations of glutamate and GABA, but to our knowledge this is the first study that shows that the effect on GABAergic transmission is direct, rather than a result of an increased glutamatergic drive. Our study directly demonstrates that at low nanomolar concentrations NO has two effects on GABAergic neurons (e.g., elevations in [Ca 2ϩ ] i and depolarization) both of which might contribute to an increase in GABAergic inhibition in the intact brain. These effects persist in the absence of glutamatergic transmission action potentials. Up to date this remained an unresolved issue, although a previous study strongly suggests that this could be the case. NO effect on [Ca 2ϩ ] i was most dramatic in putative axons, suggesting that axonal release Ca 2ϩ may be strongly potentiated by NO, which would be most effective for modulating GABA release. It now becomes important to establish whether the threshold NO concentrations required for enhancing glutamate release is different to those for GABA, as it might be that the two transmitter systems are affected at different levels of activity of NO synthases. The other unresolved issue is the mechanism of NO-induced depolarization, which has been also seen in previous studies. Based on our data with 8-Br-cADPR, which also antagonized depolarization, one could speculate that it might be a downstream effect of cADPR production.
cADPR is the link between NO and elevations in [Ca
2؉ ] i
Although previous studies suggested that in the paraventricular nucleus NO has direct effect on GABAergic interneurons, the mechanism of this effect remained unknown. We show that in the NTS GABAergic interneurons NO operates via an evolutionary conserved pathway. First described in sea urchin eggs by a previous study, this pathway involves cGMP mediated activation of cADPR production and Ca 2ϩ release. cADPR is generated from NAD by ADP-ribosyl cyclase and activates the same stores as ryanodine. Importantly, cADPR/ryanodine-sensitive stores are also responsible for the Ca 2ϩ -induced Ca 2ϩ release triggered by action potentials. Hence, the elevations in axonal [Ca 2ϩ ] i reported here may be expected to boost the actionpotential evoked Ca 2ϩ and transmitter release, as found in other cellular models (Fig. 2) . Whether the NOcGMP-cADPR-Ca 2ϩ pathway is sufficiently powerful to lead to action potential-independent GABA release at present is unclear. In general, our results are consistent with earlier studies linking NO action on Ca 2ϩ signaling with cADPR in invertebrates and with the proposed role of cADPR-operated stores in hippocampal LTD. However, to our knowledge, this is the first direct demonstration of the NO-cGMP-cADPR-Ca 2ϩ pathway in GABAergic neurons. Importantly, cADPR does not only mediate [Ca 2ϩ ] i elevations in GABAergic neurons, but it is also crucial for NO potentiation of monosynaptic GABAergic IPSP.
Several questions remain unanswered. First, we have noticed that a putative antagonist of a hypothetical separate NAADP store nifedipine (100 M) partially antagonized the effects of NO on [Ca 2ϩ ] i. Interestingly, NAADP is produced by the same enzyme that generates cADPR, the ADP-ribosyl cyclase. It would be very useful to find out the exact mechanism of this effect but more selective blockers are needed to convincingly prove a separate NAADP-dependent pathway. Second, it remains to be established whether activation of cADPR/ ryanodine-sensitive stores also underlies NO effects on glutamatergic transmission in the NTS as well as other parts of the brain. 
